MRGCX
Price
$44.59
Change
+$0.27 (+0.61%)
Updated
Sep 26 closing price
Net Assets
6.66B
VITSX
Price
$159.28
Change
+$1.00 (+0.63%)
Updated
Sep 26 closing price
Net Assets
1.95T
Interact to see
Advertisement

MRGCX vs VITSX

Header iconMRGCX vs VITSX Comparison
Open Charts MRGCX vs VITSXBanner chart's image
MFS Core Equity C
Price$44.59
Change+$0.27 (+0.61%)
VolumeN/A
Net Assets6.66B
Vanguard Total Stock Market Idx I
Price$159.28
Change+$1.00 (+0.63%)
VolumeN/A
Net Assets1.95T
MRGCX vs VITSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MRGCX vs. VITSX commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRGCX is a Buy and VITSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.95T vs. MRGCX (6.66B). VITSX pays higher dividends than MRGCX: VITSX (1.17) vs MRGCX (0.00). MRGCX was incepted earlier than VITSX: MRGCX (29 years) vs VITSX (28 years). MRGCX (1.65) is less costly to investors than VITSX (0.03). MRGCX is a more actively managed with annual turnover of: 30.00 vs. VITSX (2.00). MRGCX has a lower initial minimum investment than VITSX: MRGCX (1000) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 14.92 vs. MRGCX (2.00). VITSX return over 5 years is better than : 95.37 vs. MRGCX (44.20).
MRGCXVITSXMRGCX / VITSX
Total Expense Ratio1.640.035,467%
Annual Report Gross Expense Ratio1.650.035,500%
Fund Existence29 years28 years-
Gain YTD9.10912.26774%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets6.66B1.95T0%
Annual Yield % from dividends0.001.17-
Returns for 1 year2.0014.9213%
Returns for 3 years44.2579.1956%
Returns for 5 years44.2095.3746%
Returns for 10 years93.76248.5538%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FULC8.840.34
+4.00%
Fulcrum Therapeutics
PAC248.561.05
+0.42%
Grupo Aeroportuario del Pacifico SAB de CV Amer Dep Shares (each rep 10 Ser B shares)
ETNB14.70N/A
N/A
89bio
KAVL0.46-0.01
-2.61%
Kaival Brands Innovations Group
CNTB1.58-0.11
-6.51%
Connect Biopharma Holdings Limited